Thermo Fisher Scientific, Inc. Second Quarter Earnings Sneak Peek

S&P 500 (NYSE:SPY) component Thermo Fisher Scientific, Inc. (NYSE:TMO) will unveil its latest earnings on Wednesday, July 27, 2011. Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products.

Thermo Fisher Scientific, Inc. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for profit of 98 cents per share, a rise of 16.7% from the company’s actual earnings for the same quarter a year ago. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged and it has not changed during the last month. For the year, analysts are projecting net income of $4.13 per share, a rise of 15.7% from last year.

Get more Earnings Cheat Sheets with our in depth coverage of earnings season >>

Past Earnings Performance: The company’s quarterly results have come in above estimates for the last three quarters. Last quarter, the company booked profit of 92 cents per share versus a mean estimate of net income of 88 cents per share.

Wall St. Revenue Expectations: On average, analysts predict $2.83 billion in revenue this quarter, a rise of 6.8% from the year ago quarter. Analysts are forecasting total revenue of $11.58 billion for the year, a rise of 7.3% from last year’s revenue of $10.79 billion.

Analyst Ratings: Analysts are bullish on this stock with 13 analysts rating it as a buy, none rating it as a sell and none rating it as a hold.

Key Stats:

The company has now seen net income rise in three straight quarters. In the first quarter, net income rose 8.6% while it rose 8.9% in the fourth quarter of the last fiscal year and 21.4% in the third quarter of the last fiscal year.

Revenue rose in the first quarter after seeing a drop the quarter before. Revenue rose 1.7% to $2.72 billion in the first quarter from the year earlier. In the fourth quarter of the last fiscal year, revenue fell 2.1%.

Competitors to Watch: PerkinElmer, Inc. (NYSE:PKI), Becton, Dickinson and Co. (NYSE:BDX), Bruker Corporation (NASDAQ:BRKR), Beckman Coulter, Inc. (NYSE:BEC), Harvard Bioscience, Inc. (NASDAQ:HBIO), Bio-Rad Laboratories, Inc. (NYSE:BIO), CareFusion Corporation (NYSE:CFN), Waters Corporation (NYSE:WAT), Teleflex Incorporated (NYSE:TFX), and Quidel Corporation (NASDAQ:QDEL).

Stock Price Performance: During April 25, 2011 to July 20, 2011, the stock price had risen $6.79 (11.9%) from $56.86 to $63.65. The stock price saw one of its best stretches over the last year between September 8, 2010 and September 22, 2010 when shares rose for 11-straight days, rising 8.2% (+$3.63) over that span. It saw one of its worst periods between March 11, 2011 and March 18, 2011 when shares fell for six-straight days, falling 4.8% (-$2.67) over that span. Shares are up $8.29 (+15%) year to date.

(Source: Xignite Financials)

Get more Earnings Cheat Sheets with our in depth coverage of earnings season >>